Development
Ekso Bionics Holdings, Inc.
EKSO
$3.13
-$0.125-3.85%
NASDAQ
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 4.85M | 4.61M | 4.70M | 4.12M | 3.55M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.85M | 4.61M | 4.70M | 4.12M | 3.55M |
| Cost of Revenue | 2.48M | 2.15M | 2.45M | 2.12M | 1.87M |
| Gross Profit | 2.37M | 2.46M | 2.25M | 2.00M | 1.68M |
| SG&A Expenses | 5.05M | 4.23M | 5.14M | 5.29M | 5.77M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 8.30M | 7.54M | 8.99M | 8.57M | 7.99M |
| Operating Income | -3.45M | -2.93M | -4.28M | -4.45M | -4.44M |
| Income Before Tax | -3.21M | -3.37M | -4.23M | -4.39M | -3.18M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -3.21M | -3.37M | -4.23M | -4.39M | -3.18M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3.21M | -3.37M | -4.23M | -4.39M | -3.18M |
| EBIT | -3.45M | -2.93M | -4.28M | -4.45M | -4.44M |
| EBITDA | -2.77M | -2.59M | -4.02M | -4.03M | -4.18M |
| EPS Basic | -0.22 | -0.24 | -0.31 | -0.33 | -0.24 |
| Normalized Basic EPS | -0.14 | -0.15 | -0.19 | -0.21 | -0.15 |
| EPS Diluted | -0.23 | -0.24 | -0.31 | -0.33 | -0.24 |
| Normalized Diluted EPS | -0.14 | -0.15 | -0.19 | -0.21 | -0.15 |
| Average Basic Shares Outstanding | 14.45M | 14.07M | 13.64M | 13.30M | 13.16M |
| Average Diluted Shares Outstanding | 14.45M | 14.07M | 13.64M | 13.30M | 13.16M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |